Cell and Gene Therapy Logistics: Managing Chain of Identity, Viability, and Coordination
Cell and gene therapies (CGTs) introduce a fundamentally different supply chain model, where every...
read Details
Modality Solutions has access to the latest regulatory agency requirements for emerging new therapies. Join Modality Solutions principals Gary Hutchinson and Daniel Littlefield, in an informative webinar on successfully integrating transport simulation testing for environmental hazards into your filing strategy.
During this 45-minute pre-recorded webinar, you will take away valuable information on:
Cell and gene therapies (CGTs) introduce a fundamentally different supply chain model, where every...
read Details
Radiopharmaceuticals operate under one defining constraint: time is a non-negotiable asset. Unlike traditional biopharmaceuticals,...
read Details
Advanced therapies do not operate within traditional cold chain systems. Temperature control, timelines, and...
read Details